Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 19Rectal Neoplasms 11Colorectal Neoplasms 11Colonic Neoplasms 11Central Nervous System Neoplasms 8Stomach Neoplasms 7Carcinoma, Non-Small-Cell Lung 6Neoplasm Metastasis 5Melanoma 5Lung Neoplasms 4Liver Neoplasms 4Kidney Neoplasms 4Carcinoma, Hepatocellular 4Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Recurrence 2Prostatic Neoplasms 2Ovarian Neoplasms 2Neuroblastoma 2Lymphatic Metastasis 2Glioblastoma 2Breast Neoplasms, Male 2Astrocytoma 2Wilms Tumor 1Uveal Melanoma 1Uterine Cervical Neoplasms 1

Interventions

Granulocyte-Macrophage Colony-Stimulating Factor 1Colony-Stimulating Factors 1Chemotherapy, Adjuvant 1Chemoradiotherapy, Adjuvant 1Adjuvants, Immunologic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Resectable Pancreatic Cancer × Chemotherapy, Adjuvant × Clear all
NCT04737551 2021-02-04

Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study

Shanghai Zhongshan Hospital

Unknown
400 enrolled
Gastrointestinal

Resectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡